Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Colorectal Neoplasms

Thank you

Trial Information

Inclusion Criteria


- Patients with metastatic colorectal adenocarcinoma who have failed one prior course
of chemotherapy.

- Patients must have at least one measurable tumor.

- Patients may not have received prior treatment with oxaliplatin.

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

TEZ101

NCT ID:

NCT00051688

Start Date:

June 2003

Completion Date:

August 2004

Related Keywords:

  • Colorectal Neoplasms
  • Neoplasms
  • Colorectal Neoplasms

Name

Location

USC/Norris Comprehensive Cancer CenterLos Angeles, California  90033-0800
Comprehensive Cancer Centers of the DesertPalm Springs, California  92262
H. Lee Moffitt Cancer Center & Research InstituteTampa, Florida  33612
Kansas City Oncology and Hematology GroupKansas City, Missouri  64111
Georgetown University Medical Center, Lombardi Cancer CenterWashington, District of Columbia  20007
Cancer Institute Medical GroupLos Angeles, California  90025
ACRC/Arizona Clinical Research CenterTucson, Arizona  85712
Northwestern University Feinberg School of MedicineChicago, Illinois  60611